A proposed framework of strategies to overcome challenges to surgical quality assurance in oncology trials (SQA-Onc.).

IF 3.5 2区 医学 Q2 ONCOLOGY Ejso Pub Date : 2025-01-10 DOI:10.1016/j.ejso.2025.109593
J W Butterworth, P R Boshier, S Mavroveli, J V Reynolds, Young-Woo Kim, G B Hanna
{"title":"A proposed framework of strategies to overcome challenges to surgical quality assurance in oncology trials (SQA-Onc.).","authors":"J W Butterworth, P R Boshier, S Mavroveli, J V Reynolds, Young-Woo Kim, G B Hanna","doi":"10.1016/j.ejso.2025.109593","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Randomised controlled trials (RCTs) with surgical interventions frequently lack a framework to ensure surgical quality. We aimed to investigate surgical quality assurance (SQA) in oesophagogastric oncology trials and to develop a translatable framework of strategies to overcome challenges in the design and implementation of SQA.</p><p><strong>Methods: </strong>Seventy-one peer-nominated, international, expert trial stakeholders included surgeons; oncologists; trial managers and trial methodologists. Semi-structured interviews were conducted with expert stakeholders examining challenges to SQA in oncology trials followed by a Delphi process to gain consensus on mitigating strategies. Relevant expert consensus strategies were selected for inclusion within a separate written survey and Delphi process in the active ADDICT RCT.</p><p><strong>Results: </strong>Expert consensus was reached for 59 strategies to overcome challenges to SQA in oncology trials. 19 of these strategies were selected for inclusion within the ADDICT survey and Delphi process, of which 14 (74 %) gained consensus amongst ADDICT trial stakeholders across two Delphi rounds, indicating their relevance within an active surgical oncology RCT. Prominent mitigating strategies included operative monitoring using photographs and/or videos with a structured objective assessment tool. Summarising the expert Delphi consensus allowed formulation of a framework of strategies to overcome challenges to SQA in oncology trials (SQA-Onc.) CONCLUSION: In this first international expert consensus within this area, agreement was reached for 59 strategies to overcome challenges to implementation of SQA. The proposed SQA-Onc. tool is intended to support SQA measures within future trials. Validating this framework within the next generation of RCTs should be the focus of future research.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 5","pages":"109593"},"PeriodicalIF":3.5000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejso","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejso.2025.109593","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Randomised controlled trials (RCTs) with surgical interventions frequently lack a framework to ensure surgical quality. We aimed to investigate surgical quality assurance (SQA) in oesophagogastric oncology trials and to develop a translatable framework of strategies to overcome challenges in the design and implementation of SQA.

Methods: Seventy-one peer-nominated, international, expert trial stakeholders included surgeons; oncologists; trial managers and trial methodologists. Semi-structured interviews were conducted with expert stakeholders examining challenges to SQA in oncology trials followed by a Delphi process to gain consensus on mitigating strategies. Relevant expert consensus strategies were selected for inclusion within a separate written survey and Delphi process in the active ADDICT RCT.

Results: Expert consensus was reached for 59 strategies to overcome challenges to SQA in oncology trials. 19 of these strategies were selected for inclusion within the ADDICT survey and Delphi process, of which 14 (74 %) gained consensus amongst ADDICT trial stakeholders across two Delphi rounds, indicating their relevance within an active surgical oncology RCT. Prominent mitigating strategies included operative monitoring using photographs and/or videos with a structured objective assessment tool. Summarising the expert Delphi consensus allowed formulation of a framework of strategies to overcome challenges to SQA in oncology trials (SQA-Onc.) CONCLUSION: In this first international expert consensus within this area, agreement was reached for 59 strategies to overcome challenges to implementation of SQA. The proposed SQA-Onc. tool is intended to support SQA measures within future trials. Validating this framework within the next generation of RCTs should be the focus of future research.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
提出的战略框架,以克服肿瘤试验中手术质量保证的挑战(SQA-Onc.)。
手术干预的随机对照试验(rct)往往缺乏确保手术质量的框架。我们的目的是研究食管胃肿瘤试验中的手术质量保证(SQA),并制定一个可翻译的策略框架,以克服SQA设计和实施中的挑战。方法:71名同行提名的国际专家试验利益相关者,包括外科医生;肿瘤学家;试验管理者和试验方法学家。与专家利益相关者进行了半结构化访谈,检查肿瘤试验中SQA面临的挑战,然后进行德尔菲过程,以获得缓解策略的共识。相关的专家共识策略被选择纳入一个单独的书面调查和德尔福程序在积极的成瘾随机对照试验。结果:专家就59种策略达成共识,以克服肿瘤试验中SQA的挑战。其中19个策略被选择纳入到ADDICT调查和德尔菲过程中,其中14个(74%)在两轮德尔菲中获得了ADDICT试验利益相关者的共识,表明它们与一项活跃的外科肿瘤RCT的相关性。突出的缓解策略包括使用带有结构化客观评估工具的照片和/或视频进行操作监测。总结专家德尔菲共识允许制定战略框架,以克服肿瘤试验中SQA的挑战(SQA- onc)。结论:在这一领域的第一次国际专家共识中,达成了59项战略协议,以克服SQA实施的挑战。拟议的SQA-Onc。工具的目的是在未来的试验中支持SQA度量。在下一代随机对照试验中验证这一框架应该是未来研究的重点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Ejso
Ejso 医学-外科
CiteScore
6.40
自引率
2.60%
发文量
1148
审稿时长
41 days
期刊介绍: JSO - European Journal of Surgical Oncology ("the Journal of Cancer Surgery") is the Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery. The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.
期刊最新文献
Clinical implications of disappearing pancreatic cancer liver metastases: Lessons from colorectal liver metastases. Severe postoperative pancreatitis following treatment of peritoneal metastases. Risk factors and prognostic factors of pleural metastases in thymic epithelial tumors: A narrative review. Long-term outcomes of hepatopancreatoduodenectomy for perihilar cholangiocarcinoma: A comparative study with conventional hepatectomy. Overcoming the technical challenge of venous resection with pancreatectomy: Which factors determine survival?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1